Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cognition Therapeutics Inc

CGTX
Current price
0.51 USD +0.003 USD (+0.60%)
Last closed 0.52 USD
ISIN US19243B1026
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 18 898 630 USD
Yield for 12 month -49.50 %
1Y
3Y
5Y
10Y
15Y
CGTX
21.11.2021 - 28.11.2021

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York. Address: 2500 Westchester Ave., Purchase, NY, United States, 10577

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.2 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-252 000 USD

Last Year

-235 000 USD

Current Quarter

-67 000 USD

Last Quarter

-58 000 USD

Key Figures CGTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -58 609 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -93.7 %
PEG Ratio
Return On Equity TTM -108.31 %
Wall Street Target Price 6.2 USD
Revenue TTM
Book Value 0.57 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.93 USD
Diluted Eps TTM -0.93 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CGTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CGTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CGTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.4433
Price Book MRQ 0.8214

Financials CGTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CGTX

For 52 weeks

0.34 USD 2.95 USD
50 Day MA 0.53 USD
Shares Short Prior Month 531 392
200 Day MA 1.52 USD
Short Ratio 0.91
Shares Short 490 695
Short Percent 1.77 %